The Future of Diagnosing and Treating Autoimmune Diseases
Autoimmune diseases remain one of the biggest challenges in the medical world and pose a serious burden for the economy due to the high risk of disability and the poor prognosis for patients. Epidemiological studies show that the most common autoimmune disease is type 1 diabetes, which generally appears in childhood. At present, the causative factor of autoimmune diseases is only known in isolated cases, and most treatment strategies simply aim to contain symptoms and complications. The scientific and medical knowledge that has been gained in such areas as immunology and genetically engineered biological and cell therapy is now bringing scientists closer to understanding the causes of autoimmune destruction, which will make it possible to correctly verify the diagnosis and find fundamentally new therapeutic approaches to the effective treatment of a wide range of autoimmune diseases. How are innovative discoveries in autoimmunology changing the face of pharmacotherapy for autoimmune diseases today? What opportunities does personalized medicine offer for the diagnosis and treatment of autoimmune diseases? Can breakthrough solutions in the treatment of autoimmune diseases be integrated into practical healthcare? How close is medical science to understanding the causes of type 1 diabetes, which threatens children’s health?
Moderator
Evelina Zakamskaya,
TV Presenter, Russia 24 TV Channel; Chief Editor, Doctor TV Channel
Panellists
Sara Qiu,
Managing Director, Syai
Aleksandr Lila,
Director, V.A. Nasonova Research Institute of Rheumatology; Chief Freelance Specialist Rheumatologist of the Ministry of Health of the Russian Federation
Sergei Lukyanov,
Rector, N.I. Pirogov Russian National Research Medical University
Kirill Rodin,
Director for Work with Public Authorities, All-Russian Public Opinion Research Center
Front row participants
Gagik Galstyan,
President, Russian Diabetes Association
Yury Glukhov,
General Director, ELTA Company
Tamara Kozyreva,
Director, ANO “Agency for the Development of Initiatives in the Field of Health Care”; head of the “Help to the First” project
Elena Petryaykina,
Director, Russian Children's Clinical Hospital – Branch of N.I. Pirogov National Medical and Surgical Center of the Ministry of Health of the Russian Federation (online)
Musa Khaitov,
Director, National Research Center – Institute of Immunology of the FMBA of Russia